These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 33219005

  • 1. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM, Blanco-Redondo B, Buettner JM, Pagiazitis JG, Fletcher EV, Sime Longang JK, Mentis GZ.
    J Neurosci; 2021 Jan 13; 41(2):376-389. PubMed ID: 33219005
    [Abstract] [Full Text] [Related]

  • 2. Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy.
    Simon CM, Van Alstyne M, Lotti F, Bianchetti E, Tisdale S, Watterson DM, Mentis GZ, Pellizzoni L.
    Cell Rep; 2019 Dec 17; 29(12):3885-3901.e5. PubMed ID: 31851921
    [Abstract] [Full Text] [Related]

  • 3. Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy.
    Fletcher EV, Simon CM, Pagiazitis JG, Chalif JI, Vukojicic A, Drobac E, Wang X, Mentis GZ.
    Nat Neurosci; 2017 Jul 17; 20(7):905-916. PubMed ID: 28504671
    [Abstract] [Full Text] [Related]

  • 4. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E, Piedrafita L, Hereu M, Esquerda JE, Calderó J.
    Neuroscience; 2013 Oct 10; 250():417-33. PubMed ID: 23876328
    [Abstract] [Full Text] [Related]

  • 5. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
    Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, Van Meerbeke JP, Xu X, Davis C, Wooley J, Goldhamer DJ, Lutz CM, Rich MM, Sumner CJ.
    J Neurosci; 2012 Jun 20; 32(25):8703-15. PubMed ID: 22723710
    [Abstract] [Full Text] [Related]

  • 6. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn2B/- mouse model of spinal muscular atrophy.
    Reedich EJ, Kalski M, Armijo N, Cox GA, DiDonato CJ.
    Exp Neurol; 2021 Mar 20; 337():113587. PubMed ID: 33382987
    [Abstract] [Full Text] [Related]

  • 7. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, Thabet M, Paul B, Reilly A, Gagnon S, Renaud JM, Kothary R.
    EBioMedicine; 2020 May 20; 55():102750. PubMed ID: 32339936
    [Abstract] [Full Text] [Related]

  • 8. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
    Zhou H, Meng J, Malerba A, Catapano F, Sintusek P, Jarmin S, Feng L, Lu-Nguyen N, Sun L, Mariot V, Dumonceaux J, Morgan JE, Gissen P, Dickson G, Muntoni F.
    J Cachexia Sarcopenia Muscle; 2020 Jun 20; 11(3):768-782. PubMed ID: 32031328
    [Abstract] [Full Text] [Related]

  • 9. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R.
    Neuromuscul Disord; 2012 Mar 20; 22(3):263-76. PubMed ID: 22071333
    [Abstract] [Full Text] [Related]

  • 10. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK, Caine C, Awano T, Herbst R, Monani UR.
    Hum Mol Genet; 2017 Jul 01; 26(13):2377-2385. PubMed ID: 28379354
    [Abstract] [Full Text] [Related]

  • 11. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.
    Bowerman M, Murray LM, Boyer JG, Anderson CL, Kothary R.
    BMC Med; 2012 Mar 07; 10():24. PubMed ID: 22397316
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy.
    Lee AJ, Awano T, Park GH, Monani UR.
    PLoS One; 2012 Mar 07; 7(9):e46353. PubMed ID: 23029491
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
    Martin JE, Nguyen TT, Grunseich C, Nofziger JH, Lee PR, Fields D, Fischbeck KH, Foran E.
    J Neurosci; 2017 May 24; 37(21):5309-5318. PubMed ID: 28450545
    [Abstract] [Full Text] [Related]

  • 16. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
    Goulet BB, Kothary R, Parks RJ.
    Curr Mol Med; 2013 Aug 24; 13(7):1160-74. PubMed ID: 23514457
    [Abstract] [Full Text] [Related]

  • 17. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT, Chen CS, Jong YJ, Chang FR, Lo YC.
    Pharmacol Res; 2016 Sep 24; 111():58-75. PubMed ID: 27241020
    [Abstract] [Full Text] [Related]

  • 18. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.
    Ackermann B, Kröber S, Torres-Benito L, Borgmann A, Peters M, Hosseini Barkooie SM, Tejero R, Jakubik M, Schreml J, Milbradt J, Wunderlich TF, Riessland M, Tabares L, Wirth B.
    Hum Mol Genet; 2013 Apr 01; 22(7):1328-47. PubMed ID: 23263861
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons.
    Osman EY, Van Alstyne M, Yen PF, Lotti F, Feng Z, Ling KK, Ko CP, Pellizzoni L, Lorson CL.
    JCI Insight; 2020 Jun 18; 5(12):. PubMed ID: 32516136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.